We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Refractory livedoid vasculopathy successfully treated with baricitinib.
- Authors
Peñuelas Leal, Rodrigo; Grau Echevarría, Andrés; Martínez Domenech, Álvaro; Labrandero Hoyos, Carolina; Zaragoza Ninet, Violeta; Sanchez Carazo, Jose Luis; Alegre de Miquel, Victor
- Abstract
(b,e) Livedo racemosa, slightly attenuated retiform purpura, perimalleolar ulcers, and stellate white scars on both feet, during treatment with etanercept, aspirin, nifedipine, and pentoxifylline. It is characterized by livedo racemosa, retiform purpura, and painful ulcers that heal over 3-4 months, leaving white, atrophic stellate scars. Livedoid vasculopathy (LV) is a chronic recurrent ulcerative disease that causes significant morbidity.
- Subjects
BARICITINIB; TREATMENT effectiveness; VASCULAR diseases; TISSUE plasminogen activator
- Publication
International Journal of Dermatology, 2023, Vol 62, Issue 11, pe608
- ISSN
0011-9059
- Publication type
Article
- DOI
10.1111/ijd.16743